Schizophrenia, Treatment-Resistant: Clinical Trials

7 trials for Schizophrenia, Treatment-Resistant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown, 1 active not recruiting, 1 terminated. 7 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 47Completed 3, Unknown 2, Active not recruiting 1, Terminated 1

Follow Schizophrenia, Treatment-Resistant: new trials by email Literature Review of Schizophrenia, Treatment-Resistant trials Research Report on Schizophrenia, Treatment-Resistant

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.
Group A: (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol,anxiolytics: clonazepam, stedon, tavor antidepressants: seropram),, Group B (Pharmacotherapy and TAU) (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, antidepressants,, Group C (Pharmacotherapy and Psychotherapy) Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, lithium, depakine - Treatment Resistant Schizophrenia, Treatment Resistant Bipolar Disorder
Phase 4Active not recruitingDr. Stavroula Rakitzi842025-06-042026-05-01
Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis
Aripiprazole, Paliperidone - Schizophrenia, Treatment-resistant Schizophrenia
Phase 4UnknownConsorcio Centro de Investigación Biomédica en Red (CIBER)2442023-11-012023-09-29
Dextromethorphan as an Augmentation Agent in Treatment-resistant Schizophrenia
Dextromethorphan, Placebo - Treatment Resistant Schizophrenia
Phase 4CompletedAll India Institute of Medical Sciences, Bhubaneswar402023-08-312025-05-09
An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine
Clozapine, Antipsychotics,Other (non-Clozapine) - Treatment-resistant Schizophrenia
Phase 4TerminatedOhio State University52023-08-162026-02-25
Comparison of Maintenance ECT Versus Clozapine in Treatment-resistant Schizophrenia
Bilateral M-ECT, Clozapine - Treatment Resistant Schizophrenia
Phase 4CompletedAll India Institute of Medical Sciences, Bhubaneswar602019-02-012021-06-16
Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia
MECTA SPECTRUM 5000Q ECT, Sham ECT - Refractory Schizophrenia, Super Refractory Schizophrenia
Phase 4UnknownUniversity of Sao Paulo202010-02-012014-01-29
Amisulpride Augmentation Therapy for Clozapine-resistant Schizophrenic Patients
Amisulpride add-on, Placebo add-on - Treatment-resistant Schizophrenia
Phase 4CompletedNational Health Research Institutes, Taiwan2732006-05-012010-04-16

Narrower conditions

Schizophrenia (2)  ·  Diabetes Mellitus (1)  ·  Lipid Metabolism Disorders (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Psychotic Disorders (1)

Broader conditions

Mental Disorders (7)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (7)  ·  Schizophrenia (5)  ·  Digestive System Diseases (1)  ·  Endocrine System Diseases (1)  ·  Fatty Liver (1)  ·  Glucose Metabolism Disorders (1)  ·  Liver Diseases (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Aripiprazole (3)  ·  Clozapine (3)  ·  Paliperidone Palmitate (3)  ·  Risperidone (2)  ·  Antidepressive Agents (1)  ·  Antipsychotic Agents (1)  ·  Citalopram (1)  ·  Clonazepam (1)  ·  Clopenthixol (1)  ·  Dextromethorphan (1)  ·  Drug Therapy (1)  ·  Lithium (1)  ·  Lurasidone Hydrochloride (1)  ·  Olanzapine (1)  ·  Psychotherapy (1)

Sponsors

All India Institute of Medical Sciences, Bhubaneswar (2)  ·  Consorcio Centro de Investigación Biomédica en Red (CIBER) (1)  ·  Dr. Stavroula Rakitzi (1)  ·  National Health Research Institutes, Taiwan (1)  ·  Ohio State University (1)  ·  University of Sao Paulo (1)

Countries

India (2)  ·  Brazil (1)  ·  Greece (1)  ·  Taiwan (1)  ·  United States (1)

Top investigators

Dr. Polyxeni Georgila, M. D. (1)  ·  Dr. Stavroula Rakitzi, PhD (1)  ·  Javier Labad Arias, MD, PhD (1)  ·  Sheng-Chang Wang, M.D.,M.Sc. (1)

Results publications

PMID 10372604, PMID 10492856, PMID 15968344, PMID 16380684, PMID 16633199, PMID 17187911, PMID 19837567, PMID 25157964, PMID 25400359, PMID 25697225, PMID 26827129, PMID 27919182, PMID 28096876, PMID 29732913, PMID 35556138, PMID 41780197, PMID 9137112, PMID 9541337